Profund Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$487K Sell
59,918
-9,206
-13% -$79.1K 0.02% 557
2025
Q4
$718K Buy
69,124
+44,289
+178% +$465K 0.02% 441
2025
Q3
$220K Buy
24,835
+2,478
+11% +$17.7K 0.01% 926
2025
Q2
$129K Sell
22,357
-4,967
-18% -$30.4K ﹤0.01% 950
2025
Q1
$180K Sell
27,324
-1,034
-4% -$8.06K 0.01% 918
2024
Q4
$247K Buy
28,358
+9,490
+50% +$137K 0.01% 874
2024
Q3
$369K Sell
18,868
-4,699
-20% -$95.2K 0.01% 685
2024
Q2
$485K Sell
23,567
-25,115
-52% -$516K 0.02% 507
2024
Q1
$1.04M Buy
48,682
+23,094
+90% +$449K 0.04% 349
2023
Q4
$368K Sell
25,588
-14,033
-35% -$138K 0.02% 676
2023
Q3
$361K Buy
39,621
+3,228
+9% +$32.8K 0.02% 573
2023
Q2
$385K Sell
36,393
-14,779
-29% -$175K 0.02% 593
2023
Q1
$626K Buy
+51,172
New +$639K 0.04% 437

Other funds holding KURA